IP Library Granted Patent US 11,946,929
Granted Patent B2
US 11,946,929 · App. 18/354,144 · Granted Apr 2, 2024

Sandwich assays in droplets

Inventors: Michael L. Samuels (Windham, NH); Darren Roy Link (Lexington, MA)
Assignee: Bio-Rad Laboratories, Inc.
G01N33/54366C12Q1/6874C40B40/00C40B40/04C40B70/00G01N33/532B01F33/3011B01F33/3021C40B30/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,946,929
App. No.
18/354,144
Granted
Apr 2, 2024
Kind
B2
Abstract

The invention generally relates to performing sandwich assays in droplets. In certain embodiments, the invention provides methods for detecting a target analyte that involve forming a compartmentalized portion of fluid including a portion of a sample suspected of containing a target analyte and a sample identifier, a first binding agent having a target identifier, and a second binding agent specific to the target analyte under conditions that produce a complex of the first and second binding agents with the target analyte, separating the complexes, and detecting the complexes, thereby detecting the target analyte.

Claims (26)

1. A method comprising:

encapsulating cells and binding agents comprising oligonucleotide-linked binders into a plurality of partitions to create at least one partition containing a single cell, wherein each binding agent is provided with an oligonucleotide sequence that includes an analyte identifier specific for a target analyte and a unique identifier unique to the binding agent;

lysing the cell within the partition to release the target analyte;

binding one of the binding agents to the target analyte; and

sequencing the oligonucleotide sequence to detect the target analyte.

2. The method of claim 1 , wherein the binders are antibodies.

3. The method of claim 1 , further comprising releasing the binding agent from the partition and releasing the oligonucleotide sequence from the binding agent prior to the sequencing step.

4. The method of claim 1 , wherein each oligonucleotide sequence further includes an identifier specific for the partition.

5. The method of claim 1 , wherein the oligonucleotide sequence comprises a barcode that can be read by a nucleic acid sequencing instrument.

6. The method of claim 5 , wherein the barcode is designed to include no homopolymer repeats.

7. The method of claim 4 , wherein the identifier specific for the partition is detected to associate the detection of the target analyte with the partition.

8. The method of claim 1 , wherein the target analyte is a protein.

9. The method of claim 1 , wherein the binders are aptamers.

10. The method of claim 1 , wherein the lysing step involves exposing the cell to lysis reagents that release cellular nucleic acids, proteins, and other components from the cell.

11. A method comprising:

encapsulating cells into a plurality of partitions to create at least one partition containing a single cell, wherein the partition includes one or more binding agents, wherein the binding agents include antibodies bound to an analyte identifier for a target analyte and an identifier specific for the partition;

lysing the cell within the partition to release the target analyte;

binding the one or more binding agents to the target analyte; and

detecting the target analyte identifier, thereby detecting the target analyte.

12. The method of claim 11 , wherein the one or more binding agents include a first barcoded antibody bound to a first analyte identifier.

13. The method of claim 12 , wherein the first analyte identifier further comprises an oligonucleotide sequence that constitutes a unique identifier or barcode.

14. The method of claim 11 , wherein the identifier specific for the partition is detected to associate the detection of the target analyte with the partition.

15. The method of claim 11 , wherein the target analyte is a protein.

16. The method of claim 11 , wherein encapsulating the cells into the plurality of partitions includes diluting cells such that less than about one cell is present for every 10 partitions formed.

17. The method of claim 11 , wherein the lysing step involves exposing the cell to lysis reagents that release the cellular nucleic acids, proteins, and other components from the cell.

18. The method of claim 11 , wherein the lysing step includes one selected from the group consisting of: (1) co-flowing a lysis buffer in a laminar flow alongside the incoming cell stream in the flow path just before the partition-forming microfluidic nozzle; (2) introducing a lysis buffer within partition library reagents; (3) use of a temperature or other inducible protease or lysis reagent; (4) mechanical abrasion inside partitions traveling through microfluidic turns and constrictions; and (5) laser-induced lysis.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2023
From: SAMUELS, MICHAEL; LINK, DARREN ROY
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 065280/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2023
From: RAINDANCE TECHNOLOGIES, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 065280/0476 →
Continuity (6)
Continuation 18305650 · Apr 24, 2023
Continuation 16937908 · Jul 24, 2020
Continuation 15415276 · Jan 25, 2017
Continuation 13250702 · Sep 30, 2011
Provisional Application 61388413 · Sep 30, 2010
Related Publication 20230408505A1 · Dec 21, 2023
Cited By (1)
US 12,292,440